Centene Co. (NYSE:CNC) Shares Acquired by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its position in Centene Co. (NYSE:CNC - Free Report) by 21.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 812,210 shares of the company's stock after purchasing an additional 143,322 shares during the period. Victory Capital Management Inc. owned about 0.16% of Centene worth $61,143,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in CNC. Park Place Capital Corp raised its stake in Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company's stock valued at $29,000 after purchasing an additional 357 shares during the last quarter. WR Wealth Planners LLC lifted its stake in Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company's stock worth $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc acquired a new position in shares of Centene during the 2nd quarter valued at about $33,000. Riverview Trust Co grew its holdings in Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company's stock valued at $35,000 after buying an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Centene during the second quarter valued at approximately $36,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Performance

NYSE:CNC traded down $1.30 during trading hours on Friday, reaching $57.38. The company had a trading volume of 3,130,893 shares, compared to its average volume of 3,978,411. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Co. has a 52 week low of $57.25 and a 52 week high of $81.42. The firm has a market cap of $28.97 billion, a price-to-earnings ratio of 10.24, a PEG ratio of 0.80 and a beta of 0.49. The firm's 50 day moving average price is $68.33 and its 200-day moving average price is $71.12.

Insider Transactions at Centene

In other Centene news, CEO Sarah London bought 4,117 shares of Centene stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the acquisition, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Andrew Lynn Asher purchased 17,200 shares of the business's stock in a transaction that occurred on Wednesday, November 13th. The shares were purchased at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now directly owns 486,847 shares in the company, valued at $28,305,284.58. The trade was a 3.66 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CNC shares. Wells Fargo & Company cut their price target on Centene from $91.00 to $90.00 and set an "overweight" rating on the stock in a research note on Monday, November 4th. Barclays lowered their price target on Centene from $97.00 to $91.00 and set an "overweight" rating for the company in a report on Tuesday, October 29th. Sanford C. Bernstein decreased their price objective on Centene from $96.00 to $88.00 and set an "outperform" rating for the company in a report on Wednesday, October 30th. Cantor Fitzgerald reissued an "overweight" rating and set a $90.00 price target on shares of Centene in a research report on Tuesday, October 1st. Finally, TD Cowen increased their target price on Centene from $80.00 to $89.00 and gave the stock a "buy" rating in a research note on Wednesday, July 31st. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $83.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.